Opendata, web and dolomites
H2020 projects about "inflammatory"
The page lists 343 projects related to the topic "inflammatory".
| # | |||
|---|---|---|---|
| 1 | BIOCYCLE | BIOlogical therapy CYCLEs towards tailored, needs-driven, safer and cost-effective management of Crohn’s disease | 2015 |
| 2 | MIROCALS | Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients | 2015 |
| 3 | ImmunoAgeing | An integrated approach to dissect determinants, risk factors and pathways of ageing of the immune system. | 2015 |
| 4 | EPoS | Elucidating Pathways of Steatohepatitis | 2015 |
| 5 | CIRCODE | Cell-type specific mechanisms regulating rhythms in leukocyte homing | 2015 |
| 6 | HEARTOFSTROKE | The heart of stroke: Pipes, Perfusion, Parenchyma | 2015 |
| 7 | CrIC | Molecular basis of the cross-talk between chronic inflammation and cancer | 2015 |
| 8 | SILENCE | Mechanisms of Gene Silencing by the Glucocorticoid Receptor | 2015 |
| 9 | ComBact | How complement molecules kill bacteria | 2015 |
| 10 | MAMI | The Power of Maternal Microbes on Infant Health | 2015 |
| 11 | SOS | Sorting of Self | 2015 |
| 12 | EPIMAC | The next generation epigenetic medicine for inflammation | 2015 |
| 13 | TOLLerant | Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach. | 2015 |
| 14 | RETHRIM | Restoring tissue regeneration in patients with visceral Graft versus Host Disease. | 2015 |
| 15 | HYMADE | Hybrid Drug Delivery Systems upon Mesoporous Materials, Self Assembled Therapeutics and Virosomes | 2015 |
| 16 | GLYCO-TOOLS | Bio-Inspired Tools for Glycoscience | 2015 |
| 17 | FIND | Feasibility Assessment of a Foot INflammation Detection Device | 2014 |
| 18 | AutophagosomeSealing | Ymr1 role in the Atg proteins release from complete autophagosomes | 2015 |
| 19 | RhomBioID | Molecular mechanisms of rhomboid-like proteins in human immunity | 2015 |
| 20 | FAST-RAP | Structure-function studies of the human FASTK family of mitochondrial proteins with putative novel RNA binding domains – the helical FAST motifs and the small RAP domain | 2015 |
| 21 | Inflammafish | Cross-talk between inflammation and autophagy in tuberculosis | 2016 |
| 22 | GutILC3 | Cell-cell interactions critical to ILC3 function in the human gut | 2015 |
| 23 | IMSTREV | Immune modulation by lymph node stromal cell-derived extracellular vesicles | 2015 |
| 24 | GUTWORM | Unravelling host intestine-parasite interactions that define immune responses to whipworms | 2015 |
| 25 | RvD3-RAVIS | Novel Resolvin D3: its Role and Actions in the Resolution of Aortic Valvular Inflammation and Stenosis | 2015 |
| 26 | AuNP-PhotoBioDrug | Functionalized AuNPs and their use for biological applications | 2015 |
| 27 | WORMTUMORS | Worm power: Can helminths modify the development of colorectal cancer? | 2015 |
| 28 | iRhom2 in AD | iRhom2 in neuroinflammation and pathogenesis of Alzheimer’s Disease | 2015 |
| 29 | GLOID | Genetic and Lifestyle Origins of Inflammation in Depression | 2015 |
| 30 | Subpopulations | Investigating Fibrotic and Regenerative Fibroblast Populations in Muscular Dystrophy | 2016 |
| 31 | IPEIBD | Identification of promoters and enhancers specific for inflammatory bowel disease and its subtypes | 2015 |
| 32 | EPIRIN | EPIGENETIC REGULATION OF INFLAMMATION IN NAFLD | 2015 |
| 33 | miRNAs in TH2 cells | Role of extracellular miRNAs in T cell development, TH2 cell differentiation and TH2 cell-mediated effector function | 2015 |
| 34 | KCs and Gut Antigens | Elucidating the role of liver resident Kupffer cells in the regulation of the immune responses to intestinal antigens | 2015 |
| 35 | Beta-splicenet | ALTERNATIVE SPLICING NETWORKS IN PANCREATIC BETA CELLS | 2015 |
| 36 | TONEURENDO | In search for endothelial mechanisms of TPO-induced neuroprotection | 2015 |
| 37 | Athero MPh proliferation | Macrophage proliferation and ontogeny in murine models of atherosclerosis | 2016 |
| 38 | NanoMATe | Nanoparticles for Molecular Imaging of Atherosclerosis: from Diagnosis to Treatment | 2015 |
| 39 | COSMOS | Optical point of care system for heart failure mass screening | 2015 |
| 40 | Vaprosep | Validation of Progranulin as Biomarker in Diagnostics and Prognosis of Sepsis | 2015 |
| 41 | GAMES | Gut Microbiota in Nervous System Autoimmunity: Molecular Mechanisms of Disease Initiation and Regulation | 2015 |
| 42 | Inflammostrome | Stromal cells as primary drivers of immunopathology: towards targeted disease modification in spondyloarthritis | 2015 |
| 43 | LIFEOMEGA | Innovative highly concentrated Omega 3 food supplement | 2015 |
| 44 | DevoTed_miR | MicroRNA determinants of the balance between effector and regulatory T cells in vivo | 2015 |
| 45 | BIOXYARN | In vitro evaluation of the biocompatibility of nanofibrous yarns from an oxidative stress perspective | 2015 |
| 46 | ENVIROIMMUNE | Environmental modulators of the immune cell balance in health and disease | 2015 |
| 47 | GliaInnateSensing | Glia-derived factors in innate lymphoid cell sensing and intestinal defence | 2015 |
| 48 | IMMUNOBIOME | Identifying microbiotal triggers of inflammatory bowel disease through the lens of the immune system | 2016 |
| 49 | STROMA | IMMUNOBIOLOGY OF LYMPHOID STROMAL CELLS | 2015 |
| 50 | Novel asthma therapy | Biocompatible nanoparticles for T cell targeted siRNA delivery as novel asthma therapy | 2015 |
| 51 | miRNA in Immunity | Testing the role of miRNA-mediated non-cell autonomous gene regulation in type-2 immunity | 2015 |
| 52 | APOLs | Role of Apolipoproteins L in immunity and disease | 2015 |
| 53 | PHII | PTX3 in Humoral Innate Immunity | 2015 |
| 54 | ZAUBERKUGEL | Fulfilling Paul Ehrlich’s Dream: therapeutics with activity on demand | 2015 |
| 55 | MASSTRPLAN | MASS Spectrometry TRaining network for Protein Lipid adduct ANalysis | 2015 |
| 56 | LeukoTheranostics | Harnessing Targeted Nanotheranostics to Reprogram Activated Leukocytes in Inflammatory Bowel Disease | 2015 |
| 57 | PERIF | Perivascular cells at the crossroads of inflammation, regeneration and fibrosis | 2015 |
| 58 | TRAIN-ERS | Endoplasmic Reticulum Stress in Health and Disease | 2015 |
| 59 | FrEBT | Improving diagnostics of respiratory diseases and boosting the COMAC MEDICAL Ltd. competitiveness and growth by validation of fractional EBT biomarker through new method of measurement and device | 2015 |
| 60 | iPROTECTION | Molecular mechanisms of induced protection against sepsis by DNA damage responses | 2015 |
| 61 | AcTafactors | AcTafactors: Tumor Necrosis Factor-based immuno-cytokines with superior therapeutic indexes | 2015 |
| 62 | SEPCELL | Title of Proposal: Restoring the immune system homeostasis and organ function in severe community acquired pneumonia- induced sepsis through adipose derived allogeneic stem cells (SEPCELL Proje | 2015 |
| 63 | TACTICS | Transferring Activomics into the Clinical Setting | 2015 |
| 64 | PREG-LAB | Distinctive characterization of regulatory plasma cells and pro-inflammatory B cells in immunity: their origins, molecular properties, and cellular fates. | 2016 |
| 65 | REPROGRAM | Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseases | 2016 |
| 66 | PIBD-SETQuality | Paediatric Inflammatory Bowel Diseases Network for Safety, Efficacy, Treatment and Quality improvement of care | 2016 |
| 67 | RELENT | RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities | 2015 |
| 68 | IMPEDE | Immunomodulatory effects of sustained pantethine release in inflammatory diseases | 2016 |
| 69 | SMARTool | Simulation Modeling of coronary ARTery disease: a tool for clinical decision support | 2016 |
| 70 | SAFEIMMUNOSUPPRESS | Development of immunosuppressive treatments with better safety | 2016 |
| 71 | PAIR | Physical Activity, Inflammation and Respiratory health: an integrative analysis of biological, behavioural and environmental determinants | 2016 |
| 72 | RITA-MI | Rituximab in Acute Myocardial Infarction | 2016 |
| 73 | LDC4PCaTher | BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 |
| 74 | CMIL | Crosstalk of Metabolism and Inflammation | 2016 |
| 75 | MCTRinIA | Resolution Pharmacology and Physiology of MCTR in Arthritis | 2016 |
| 76 | MAST4HEALTH | Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH). | 2016 |
| 77 | MOMENDO | Molecular Mechanisms of Endometriosis | 2016 |
| 78 | NEUTRO-LILR | Leukocyte immunoglobulin-like receptors (LILRs) on neutrophils | 2016 |
| 79 | MICRO-MACRO-ILC | Dissecting the human microbiota-macrophage-innate lymphoid cell crosstalk in the lung | 2016 |
| 80 | LIPID IMMUNITY | Regulation of lipid-mediated immunity in the intestine | 2016 |
| 81 | RAMSES | Aryl amide metallofoldamersas selective saccharide sensors | 2016 |
| 82 | Gut-InflammAge | Age-associated signatures in the composition and pro-inflammatory status of the gut microbiome in humans and mice, and the impact of a periodic fasting intervention to promote healthy aging | 2016 |
| 83 | GENDER-CF | Gender-related differences in expression of microRNAs in cystic fibrosis | 2017 |
| 84 | ZF-ILC | Characterization of zebrafish innate lymphoid cells and IL-22 | 2017 |
| 85 | SUMOWO | Surface modulation of wounds: heal by inhalants!Novel drug-based treatment for excessive scars and chronic wounds. | 2016 |
| 86 | DeBoRA | Dopamine and Bone Metabolism in Rheumatoid Arthritis | 2016 |
| 87 | InnateMSDyn | Combining in vivo spectral biphoton imaging and multiparametric cytometry to characterize the dynamics of the innate immune response in a multiple sclerosis mouse model | 2016 |
| 88 | REGDAM | REGULATORY T CELLS AND TISSUE DAMAGE CONTROL | 2017 |
| 89 | SMILED | Skeletal Muscle Inflammation: ambivalent roles in Exercise and Diabetes | 2016 |
| 90 | Toxoplasma sensing | Cytoplasmic sensing of Toxoplasma gondii infection and host cell programmed necrosis | 2016 |
| 91 | PANDORA | Platelets: at the nexus of brain aneurysm | 2016 |
| 92 | IMCIS | Individualised medicine in chronic inflammatory skin diseases | 2016 |
| 93 | iRELaTE | Immune Response and Social Cognition in Schizophrenia | 2016 |
| 94 | VIREX | Mumps VIRus EXploitation of the human adhesion receptor GPR125 | 2016 |
| 95 | DEMETINL | Decisions in metabolic inflammation of the liver: Adhesive interactions involved in leukocyte retention and resolution of inflammation in metabolic-inflammatory liver disease | 2017 |
| 96 | PyroPop | Mechanisms and regulation of inflammasome-associated programmed cell death | 2017 |
| 97 | Microbes4U | Study of the therapeutic potential of an Akkermansia muciniphila-based products in subjects with an increased cardio-metabolic risk. | 2016 |
| 98 | CoBABATI | Cofactor Binding Antibodies – Basic Aspects and Therapeutic Innovations | 2016 |
| 99 | DrugSynergy | DrugSynergy: A data-driven systems biology approach to optimize drug combination strategies | 2016 |
| 100 | StemHealth | Foetal Intestinal Stem Cells in Biology and Health | 2016 |
| 101 | PROVASC | Cell-specific vascular protection by CXCL12/CXCR4 | 2016 |
| 102 | RAMBO | Mitochondrial DNA degradation and sterile inflammation in the heart | 2016 |
| 103 | MEDICI | The inflammatory gene expression program in macrophages: An integrative approach for the systematic characterization of transcriptional co-regulators | 2016 |
| 104 | CrUCCial | Novel diagnostic and therapeutic approach to inflammatory bowel disease based on functional characterization of patients: the CrUCCial index | 2016 |
| 105 | X-10 Pathology | X-10 Pathology, Empowering diagnostics | 2016 |
| 106 | ERYTHROAG | A new ICT-based device (RHEO-01) for fast point-of-care analysis of acute ischemic stroke and other emergency situations. | 2016 |
| 107 | HypoFlam | Targeting hypothalamic inflammation in obesity and diabetes | 2016 |
| 108 | GlySign | Exploitation of Glycosylation Signatures for Precision Medicine | 2016 |
| 109 | chemos | Chemical Hematology: breaking resistance of hematological malignancies through personalized drug trials | 2016 |
| 110 | Diet-namic | From fast food to healthy diet: Addressing the dynamic molecular mechanism of sequential diet switch-induced T cell plasticity for the purpose of developing new treatments for immuno-mediated diseases | 2016 |
| 111 | NEW DEAL | New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinases | 2017 |
| 112 | CD40-INN | CD40 goes innate: defining and targeting CD40 signaling intermediates in the macrophage to treat atherosclerosis | 2016 |
| 113 | GUTPEPTIDES | Novel therapeutic approaches to improve gastrointestinal wound healing | 2017 |
| 114 | CAVEHEART | Heart regeneration in the Mexican cavefish: The difference between healing and scarring | 2017 |
| 115 | NOTID | Novel treatment of inflammatory diseases | 2016 |
| 116 | Fucoderm | An effective, side effect-free topical emollient treatment for atopic dermatitis made from a sustainably procured seaweed extract | 2016 |
| 117 | theEoE | A novel drug candidate for the treatment of Eosinophilic Esophagitis - an innovative solution for a significant unmet medical need | 2016 |
| 118 | LIVERHOPE | SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS | 2017 |
| 119 | SYSCID | A Systems medicine approach to chronic inflammatory disease | 2017 |
| 120 | BETA-BACT | Beta-cell inflammation and dysfunction induced by bacterial translocation | 2016 |
| 121 | miRCaP | Innovative nanoparticle formulation for a miR-133 based treatment of cardiac hypertrophy | 2016 |
| 122 | MODulATE | Gut microbiota-dependent tryptophan metabolism: role in disease pathogenesis and therapeutic target | 2017 |
| 123 | MultipleMS | Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine | 2017 |
| 124 | PIMS | Mechanistic studies of long chain omega-3 fatty acid supplementation and inflammation in metabolic syndrome. | 2017 |
| 125 | IMMUNE CELL SWARMS | Innate Immune Cell Swarms: Integrating and Adapting Single Cell and Population Dynamics in Inflamed and Infected Tissues | 2017 |
| 126 | INVESTIGERFE | Investigating the regulation of iron homeostasis by erythroferrone and therapeutic applications | 2017 |
| 127 | MaRiA | Microbiota and Resolvins in Arthritis | 2017 |
| 128 | Plat-IL-1 | Pathophysiology of platelet-derived Interleukin 1 | 2017 |
| 129 | POLYAMACHINES | The polyA machinery: Elucidating the molecular mechanisms of mRNA polyadenylation, deadenylation and RNA recognition | 2017 |
| 130 | Cytokineproteomics | Investigating inflammatory signaling by combining phospho- and ubiquitin proteomics with CRISPR/Cas9 technology | 2017 |
| 131 | MIRA | Characterizing Microbe-specific Immune Responses in the pathogenesis of Autoimmunity | 2017 |
| 132 | MAREXT | Macrocyclic receptors for selective anion extraction | 2018 |
| 133 | Schizo-EPICOG | Inflammatory processes underlying cognitive deficits in schizophrenia: epigenetic mechanisms and pharmacological regulation | 2018 |
| 134 | ColoFILM | Multifunctional polymeric film-based drug delivery system for oral anti-TNF-alpha-based inflammatory bowel disease therapy | 2017 |
| 135 | IMMUNO_CRC | Microbiota-immune interaction in colorectal cancer | 2017 |
| 136 | PROGLUTASIS | Protection of cardiometabolic inflammation by modulation of myeloid glutamine homeostasis | 2017 |
| 137 | DIRECtA | Targeting the Endocannabinoid System within Islets of Langerhans to Protect against Immune Destruction. | 2018 |
| 138 | MArylAND | At the host-bacteria interface: Modulation of the intestinal microbiota and its metabolic activity by Card9 signalling in health and Inflammatory Bowel Diseases | 2017 |
| 139 | Glyco-Platforms | Novel smart glyco-nanomaterials as targeted therapeutics. | 2017 |
| 140 | TNFaLysMyr | Unique TNFα lysine myristoylation; elucidating its function, regulation and integration into inflammation | 2018 |
| 141 | CD4CRISPR | A quorum sensing mechanism regulating CD4 T cell proliferation | 2017 |
| 142 | VWF and NETs | Investigating the interplay between VWF, platelets, and neutrophil extracellular traps in pathologies involving thrombosis of the microvasculature | 2017 |
| 143 | MUC | The microbial degradation and utilization of mucin by Bacteroides in ulcerative colitis | 2017 |
| 144 | RoNDBioCan | NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway | 2018 |
| 145 | DSMT16 | Deciphering causes and consequences of inflammation in subtypes of sporadic intestinal cancer | 2018 |
| 146 | MARS | Can histone code-like switches govern the multifunctionality of RNA-binding proteins? | 2017 |
| 147 | InflammaTENSION | A study of the roles of the immune and inflammatory systems in hypertension. | 2017 |
| 148 | ILMET | Metabolic characterization of ILCs under homeostatic or stress conditions. | 2017 |
| 149 | TANTUMorNEUVACCINE | Neutrophil subtypes: distinct cellular targets for therapeutic intervention | 2017 |
| 150 | Signalling-in-NODs | Investigation of the role and mechanism of action of NOD2-mediated isoform selective PI3K signalling in gut immunity and inflammation | 2017 |
| 151 | CFZEBRA | Balancing the immune response in cystic fibrosis: using zebrafish models of infection and inflammation to uncover new therapeutic approaches | 2017 |
| 152 | LUMABS | Therapeutic antibody drug monitoring using bioluminescent sensors proteins and a smartphone | 2017 |
| 153 | EpiFAT | Epigenomic Reprogramming of Adipose Tissue Function and Energy Metabolism in Type 2 Diabetes | 2017 |
| 154 | HHMM-Neonates | DEVELOPMENT OF HEALTHY HOST-MICROBIAL MUTUALISM IN EARLY LIFE | 2017 |
| 155 | NEMESIS | Neuron/mast cell interactions in skin diseases | 2017 |
| 156 | METAMAPPER | Super-resolution genomic mapping for the microbiome | 2017 |
| 157 | NeurIMM | Neuroimmune activation as a novel therapeutic approach for IBD | 2017 |
| 158 | PROBIOTEARS | Probiotic-based Ophtalmologic treatment for Bacterial and Allergic Conjunctivitis | 2017 |
| 159 | SYN1002 | A New Therapeutic Option to Protect Central Nervous System against Acute Ischemic Stroke | 2017 |
| 160 | MACULA2 | Commercialising a novel diagnostic panel for patient stratification in Age-related MACULAr Degeneration | 2017 |
| 161 | DRIVE | Driving next generation autophagy researchers towards translation | 2017 |
| 162 | CURE | Constructing a ‘Eubiosis Reinstatement Therapy’ for Asthma | 2017 |
| 163 | CSI-Fun | Chronic Systemic Inflammation: Functional organ cross-talk in inflammatory disease and cancer | 2018 |
| 164 | X-TAM | Dissecting Cross-Regulatory Interplays in Tumor-Associated Macrophages | 2018 |
| 165 | OACTIVE | Advanced personalised, multi-scale computer models preventing OsteoArthritis | 2017 |
| 166 | MOODSTRATIFICATION | Immune Signatures for Therapy Stratification in Major Mood Disorders | 2018 |
| 167 | TRIBAL | A TRranslational approach to Identify Biomarkers for Asthma and Lung function impairment | 2017 |
| 168 | TissueLymphoContexts | Tissue-resident Lymphocytes: Development and Function in “real-life” Contexts | 2018 |
| 169 | MODVASC | Endothelial RNA Modifications in Vascular Homeostasis and Disease | 2018 |
| 170 | NanoSurf | Nanostructural surface development for dental implant manufacturing | 2018 |
| 171 | RESTORE | NEURONAL SELF-RENEWAL BY ANTIGEN-SPECIFIC TOLERIZATION IN MULTIPLE SCLEROSIS REINSTALLING THE BALANCE BETWEEN INFLAMMATION AND REGENERATION | 2018 |
| 172 | N-IF | The N-IF mouse – a new and unique fibrosis model for preclinical efficacy studies | 2017 |
| 173 | EpiCBiome | Development of an innovative Airway-on-Chip microbiome cell culture model to investigate host-microbiome interactions at the airway epithelial surface | 2018 |
| 174 | Damocles | Modelling brain aneurysm to elucidate the role of platelets | 2018 |
| 175 | REBUILDCNS | Redirecting glial progenitor fate to rebuild the injured Brain | 2018 |
| 176 | Living Bionics | Living bioelectronics: Bridging the interface between devices and tissues | 2018 |
| 177 | peLabDisk | Point-of-care molecular diagnostics of psoriasis and eczema – peLabDisk | 2018 |
| 178 | METACELL | Metabolism of a cell pictured by single-cell approach | 2018 |
| 179 | UTERUS | Unravelling gamma delta T cell emergence and responses in the uterus | 2018 |
| 180 | InflamCellDeath | Mechanism and function of gasdermin-induced inflammatory cell death | 2018 |
| 181 | SmallDrugRheuma | Discovery of Immune Therapeutic Targets and Immunomodulators for the Development of Novel Therapies in Rheumatoid Arthritis. | 2018 |
| 182 | POLYTHEA | Design and photo-optimization of Photosensitizer for Human Health and Food security applications or “how light can save lives” | 2018 |
| 183 | NIRCOThera | Spatiotemporal, near-infrared light controlled carbon monoxide delivery for cancer immunotherapy | 2018 |
| 184 | EFHHBBBMS | Endothelial Hedgehog autocrine signaling at the Blood Brain Barrier controls inflammatory CentralNervous System lesion size and severity through Gas1 co-receptor modulation. | 2019 |
| 185 | IRONAGE | Iron as a driver of fibrosis and regeneration | 2018 |
| 186 | BREFMC2017 | Deciphering the function(s) of the C-type lectin DCIR/CLEC4A in tuberculosis | 2018 |
| 187 | CORLINK | The therapeutic potential of Genipin as a corneal cross-linking agent: Unlocking a new pathway for the treatment of corneal infection and disease. | 2019 |
| 188 | cureCD | Function of long non-coding RNA in Crohn Disease Ulcer Pathogenesis | 2018 |
| 189 | EATing more | Enhancing Engulfment of Apoptotic cells: basic biology to Therapy | 2018 |
| 190 | DC_Nutrient | Investigating nutrients as key determinants of DC-induced CD8 T cell responses | 2018 |
| 191 | SynBioBrain | Building biological computers from bacterial populations | 2018 |
| 192 | MetChromTx | Macrophage metabolism and signal-induced chromatin and transcription changes: an integrated, multi-layer approach | 2018 |
| 193 | REPROGRAMIT | Control of T cell differentiation and plasticity through mitochondrial reprogramming | 2019 |
| 194 | TREGinAD | Role of Aβ Specific Regulatory T cells in harnessing cerebral Aβ clearance in Alzheimer’s Disease | 2018 |
| 195 | MICROBE | Metagenomic Investigation of Cow Reproductive Biology and Ecology | 2018 |
| 196 | ART-BONE | Manufacturing of Artificial Bone for Repair and Regeneration of Large Osseous Defects | 2018 |
| 197 | INBID | Improving the resolution of Neuroinflammation during repetitive mild Traumatic Brain Injury with dietary fatty acid Derivatives | 2018 |
| 198 | PREMNEC | PReterm Enteroids to determine the Mechanism of Necrotising EnteroColitis | 2018 |
| 199 | VIAR | Virus-induced autophagy restriction | 2018 |
| 200 | Gal3-BrainMets | A novel immunotherapy against brain metastasis: Anti-Galectin-3 | 2019 |
| 201 | PAMpeR | Patroller monocytes as modulators of diabetic retinopathy | 2018 |
| 202 | MECoCaM | Human gut Microbiome, gene Expression and Colorectal Cancer: Assigning causal roles from a novel Mendelian randomization perspective. | 2018 |
| 203 | COAGULANT | CK2-dependent cytoskeletal regulation and molecular signaling of Neutrophil Extracellular Trap (NET) formation | 2018 |
| 204 | NeMESIS | Neuron-based Monitoring Electrochemical Bio-Sensor Interface System | 2019 |
| 205 | SPArKLE | New players in immunometabolism: investigating the role of succinate and pyruvate kinase in T cell immunity | 2018 |
| 206 | EpiBarrier | Control of the blood-brain barrier integrity during seizures via the ATP-gated P2X7 receptor | 2018 |
| 207 | MEXOM | Development and characterization of extracellular vesicles an innovative cell-free therapeutical product for treatment of stroke | 2018 |
| 208 | GLIAMAC | Uncovering Enteric GLIA-MACrophage communication in the intestinal homeostasis and inflammation | 2018 |
| 209 | Multiple Sclerosis | Development of a Functionalised Biomaterial Scaffold to Treat Multiple Sclerosis | 2018 |
| 210 | INFLA-AID | The role of NLRC4 inflammasome in autoinflammatory diseases | 2018 |
| 211 | QuanTII | Quantitative T cell Immunology and Immunotherapy | 2018 |
| 212 | PhaseControl | How cellular suicide programmes control phase transitions in fatty liver disease and liver cancer | 2018 |
| 213 | DCPOIESIS | Steady-state and demand-driven dendritic cell generation | 2018 |
| 214 | NECROPTOSIS | Necroptosis in immunity, inflammation and autoimmunity induced by nucleic acid sensors | 2018 |
| 215 | BASILIC | Decoding at systems-level the crosstalk between the T cell antigen receptor, the CD28 costimulator and the PD-1 coinhibitor under physiological and pathological conditions. | 2018 |
| 216 | E-T1IFNs | Elaboration of the type I interferonopathies | 2018 |
| 217 | ONCOTICS | Probiotics for the Oncological Patients | 2018 |
| 218 | FasNaGel | NOVEL THERAPEUTIC NANOHYDROGEL FOR ACUTE AND CHRONIC PAIN TREATMENT TARGETED TO THE NERVES FASCIA | 2018 |
| 219 | RheumArth | New drug for the treatment of rheumatoid arthritis | 2018 |
| 220 | TOBeATPAIN | Targeting neuroinflammation to combat pathological pain in neurodegenerative diseases and chronic pain syndromes | 2018 |
| 221 | TLA-Gut | Novel Personalized Cellular Therapy Approach for Immune Diseases | 2018 |
| 222 | MINAPATH | MINAPATH: A novel and unique method to diagnose and prevent diseases that are caused by exposure and accumulation of inorganic mineral dusts. | 2018 |
| 223 | PermeAbility | PermeAbility - A non-invasive, side-effect-free diagnostic kit for intestinal disorders | 2018 |
| 224 | SkinKer | Absorbable and wearable keratin-based nanofibers for wound healing and skin reconstruction | 2018 |
| 225 | Simecos | A New Adjuvant Nutraceutical from the North Atlantic Ocean for Breast, Lung and Pancreatic Cancer Patients | 2018 |
| 226 | PaSION | A longitudinal assessment of treatment experience, symptoms and potential associations with biomarkers in cancer patients undergoing immune checkpoint inhibitor therapy | 2018 |
| 227 | ENDONANO | Quantitative detection of bacterial endotoxin by novel nanotechnological approaches | 2019 |
| 228 | GROWTH | Research and Training in Early Life Nutrition to Prevent Disease | 2019 |
| 229 | MaeBAia | Mechanisms of adverse effects of Beta-Agonists in Asthma | 2018 |
| 230 | MicroTher | MicroTher: Drug Discovery from the Microbiota | 2018 |
| 231 | ActinSensor | Identification and characterization of a novel damage sensor for cytoskeletal proteins in Drosophila | 2019 |
| 232 | EPI-X4Health | Therapeutic potential of optimized derivatives of an endogenous CXCR4 antagonist for the treatment of cancers and inflammatory diseases | 2018 |
| 233 | LIFT | Liquid Foam Therapy (LIFT) for Acute Respiratory Distress Syndrome (ARDS) | 2018 |
| 234 | ImAgine | Exploring the link between innate Immunity and cellular Aging | 2019 |
| 235 | RiboInflam | Assessing the role of ribosomes and mRNA translation in shaping the inflammatory response | 2019 |
| 236 | Notid | Novel Target for Treatment of Chronic Inflammatory Diseases | 2018 |
| 237 | DDRMac | DNA Damage Response-instructed Macrophage Differentiation in Granulomatous Diseases | 2019 |
| 238 | BRuSH | Oral bacteria as determinants for respiratory health | 2019 |
| 239 | kINPen | Developing a high-innovative portable cold plasma device for efficient healing of chronic wounds in veterinary medicine | 2019 |
| 240 | ADMAIORA | ADvanced nanocomposite MAterIals fOr in situ treatment and ultRAsound-mediated management of osteoarthritis | 2019 |
| 241 | EVPRO | EVPRO - Development of Extracellular Vesicles loaded hydrogel coatings with immunomodulatory activity for Promoted Regenerative Osseointegration of revision endoprosthesis | 2019 |
| 242 | RESTORE | User-centred smart nanobiomaterial-based 3D matrices for chondral repair | 2019 |
| 243 | LIMBo | Zooming the link between diet and brain health: how phenolic metabolites modulate brain inflammation | 2019 |
| 244 | The MATRIX | Inflammatory resolution and remodelling of the adipose extracellular matrix: key determinants of a metabolically healthy phenotype? | 2019 |
| 245 | EpiTune | Epigenetic fine-tuning of T cells for improved adoptive cell therapy | 2019 |
| 246 | INFLAME | Deciphering the host and microbial grounds that license inflammasome-mediated execution | 2018 |
| 247 | EUPHORIA | Enhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal Abnormalities | 2019 |
| 248 | StopAutoimmunity | Recurrent disease in the liver transplant: window to identify and stop gut signals driving autoimmunity | 2019 |
| 249 | NEOCANTAL | New Oleocanthal-based functional ingredients with anti-inflamatory properties obtained from olive pomace valorisation | 2019 |
| 250 | SEPSCAV | SCAVENGING ON SEPSIS. DEVELOPMENT OF SEPSIS SPECIFIC DRUGS FROM HUMAN SCAVENGER RECEPTORS | 2019 |
| 251 | PRinTERs | Post-transcriptional regulation of effector function in T cells by RNA binding proteins | 2019 |
| 252 | APOSITE | Apoptotic foci: composition, structure and dynamics | 2019 |
| 253 | ViroPedTher | Oncolytic viruses for the treatment of pediatric brain tumors: An integrated clinical and lab approach | 2019 |
| 254 | Epi4MS | Targeting the epigenome: towards a better understanding of disease pathogenesis and novel therapeutic strategies in Multiple Sclerosis | 2019 |
| 255 | STEP 2 | Spatiotemporal regulation of T-cell Priming | 2019 |
| 256 | MEFISTO | MEFISTO - Meniscal functionalised scaffold to prevent knee Osteoarthritis onset after meniscectomy | 2019 |
| 257 | IDENSTEM | Identification and characterization of enteric nervous system stem cells | 2020 |
| 258 | RoBE | Study of the role of BANK1 in antibody production and antibody-independent functions of B cells in SLE | 2019 |
| 259 | I-AM-GUT | Impact of maternal Adrenomedullin on the Microbiome and Gut health: insights into preventing chronic intestinal disorders | 2019 |
| 260 | IMPACT | Immune Mechanisms of Necrotic DNA Phagocytosis by Neutrophils: A Role for Integrins | 2020 |
| 261 | EOBRECA | Differential Roles of Estrogens in Obesity-mediated ER+ Breast Cancer Development | 2019 |
| 262 | CM_GF | Biological relevance of the multiple infection unit as a novel target for antiviral development | 2020 |
| 263 | DECOMPACT | Development of Collagenase Polymeric nanocapsules as Therapeutics | 2019 |
| 264 | Inflapoptosis | Gasdermin D is a novel effector in the extrinsic apoptosis pathway | 2019 |
| 265 | iRhomADAM | Uncovering the role of the iRhom2-ADAM17 interaction in inflammatory signalling | 2020 |
| 266 | StopIG | Translating fundamental insights in podocyte metabolism and cell cycle regulation: development of a new treatment for Stopping crescentic Immune Glomerulonephritis | 2019 |
| 267 | IA-NANO | Albumin particles for intra-articular delivery of celecoxib to treat osteoarthritic inflammation. | 2019 |
| 268 | MAGI | Microbial therapy against gut inflammation | 2019 |
| 269 | INF-CVD | Chronic inflammation and cardiovascular risk | 2019 |
| 270 | CAR-OAC | Carotid-artery-on-a-chip device to model thromboembolisms induced by vascular lesions and perform drug screenings | 2020 |
| 271 | SynGut | Molecular, morphological, and functional requirements for gastrointestinal serotonin release | 2020 |
| 272 | PMSMatTrain | Novel Biomaterial-based Device for the Treatment of Progressive MS- - An Integrated Pan- European Approach | 2019 |
| 273 | NEUROSKIN | Modulating skin innervation to treat cutaneous inflammation | 2019 |
| 274 | MacMeninges | Control of Central Nervous Sytem inflammation by meningeal macrophages, and its impairment upon aging | 2019 |
| 275 | MIMIC | Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy | 2020 |
| 276 | LinkFM | Linking Functional impact and Microstructural properties of fiber tract demyelination and remyelination in a rodent model of multiple sclerosis | 2019 |
| 277 | miR-IBD | Fecal miRNAs, new mediators of host-microbiota interaction in Inflammatory Bowel Disease | 2019 |
| 278 | REMAKIN | REstoring myocardial repair capacity via the modulation of MAcrophage-mediated cytoKINe secretion. | 2019 |
| 279 | Vetherapy | Regenerative medicine for cost- and time-efficient pet treatment | 2019 |
| 280 | NeoCellBank | A revolutionary regenerative therapy for management of chronic inflammatory diseases based on neonatal Mesenchymal Stem Cells | 2019 |
| 281 | TUBE | Transport derived Ultrafines and the Brain Effects | 2019 |
| 282 | ENTRAIN | ENdoThelial macRophage Alliance In Neuroinflammation | 2019 |
| 283 | Metabinnate | Metabolic crosstalk in the regulation of inflammation | 2019 |
| 284 | SCOPE | Schwann Cell Options for chronic Pain Eradication | 2019 |
| 285 | ePANC-SPLICE | Regulation and Function of Endocrine-Specific Splicing Programs in Pancreas and their Role in Diabetes | 2020 |
| 286 | ScleroTest | A rapid and cost-effective point-of-care diagnostic kit able to predict treatment response for appropriate Multiple Sclerosis management | 2019 |
| 287 | INITIATE | INnate-ImmunomeTabolIsm as Antiviral TargEt | 2019 |
| 288 | FRC BioEnergetics | Functional dissection of metabolic checkpoints in lymph node fibroblastic reticular cells | 2020 |
| 289 | INVADERS | Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease | 2019 |
| 290 | IMMUNOTHROMBOSIS | Cross-talk between platelets and immunity - implications for host homeostasis and defense | 2019 |
| 291 | ADDEGE | Dramatically improving chronic knee pain from osteoarthritis using an active steering telescopic microcatheter device in conjunction with a new ultra-low friction hydrophilic coating | 2019 |
| 292 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
| 293 | TRACER | TRAF-STOP therapy to reduCe inflammation in athERosclerosis. | 2020 |
| 294 | BIOXPLOR | BioXplor’s AI/Cognitive Software Platform accelerates and greatly reduces the cost of discovery research and clinical trials, with a primary focus on rare and inflammatory diseases data. | 2019 |
| 295 | Mirnagreen | First scalable food-grade technology for the direct extraction and purification of miRNAs-rich extracts from plants | 2019 |
| 296 | TRS | A paradigm change in the treatment of blinding ocular diseases | 2019 |
| 297 | StaphIMPACT | SA.100: Next-generation targeted antibacterial product entering European market | 2019 |
| 298 | TEXAD | TEXAD – Tailoring EXosomes for Autoimmune Diseases | 2019 |
| 299 | Immune-Image | Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies | 2019 |
| 300 | ANIMATE | Adaptive Immunity in Human Atherosclerosis: Understanding its Cellular Basis to Define Novel Immunomodulatory Therapies | 2020 |
| 301 | NanoGut | Exploiting the pathophysiology of the gut towards innovative oral peptide delivery strategies | 2020 |
| 302 | MyeFattyLiver | Unravelling the heterogeneity and functions of hepatic myeloid cells in Non-Alcoholic Fatty Liver Disease | 2019 |
| 303 | Obsidian | Obsidian Anastomotic SafeGuard – A powerful and efficient tissue sealant method for reducing the anastomotic leak rate in colorectal surgery | 2019 |
| 304 | CAESAR | Developing Therapeutic Antibodies for Pets | 2019 |
| 305 | HyperBiota | Exploring the diet-microbiota axis for immunomodulation and organ protection in hypertension | 2020 |
| 306 | InflaCare | An exosome-based therapeutic approach against chronic inflammation | 2020 |
| 307 | IBDetect | Point of Care Diagnostic Test for the Differential Diagnosis of Inflammatory Bowel Disease | 2019 |
| 308 | InflaPML | Promyelocytic leukemia protein (PML) outside the tumor: a new player in the control of inflammation | 2020 |
| 309 | CardioProtectMI | A New Drug Therapy for the treatment of ST Elevated Myocardial Infarction | 2019 |
| 310 | SMA-TB | A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients. | 2020 |
| 311 | DocTIS | DECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMIDS USING SYSTEMS APPROACHES | 2020 |
| 312 | DIAMONDS | Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis | 2020 |
| 313 | ExocyTher | Extracellular vesicle production and engineering by turbulence for fistula therapy in thermoreversible hydrogels | 2020 |
| 314 | BARRIER BREAK | Breaking the barrier: How inflammation spreads from skin to joint | 2020 |
| 315 | WINTHER | Fast optoacoustic mesoscopy, using the skin as a window for therapeutic monitoring of local and systemic disease. | 2020 |
| 316 | VANGUARD | New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes | 2020 |
| 317 | MInfla-Tilc | Generation of therapeutic antibodies targeting type 2 Innate Lymphoid cells in asthma | 2020 |
| 318 | IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases | 2019 |
| 319 | PANACHE | Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases. | 2020 |
| 320 | NanoGlia | Understanding the impact of nanoplastics on the development of neurological disorders | 2020 |
| 321 | PHYRIST | Physiological roles of the Ribotoxic Stress Response | 2020 |
| 322 | GUT-SEQ | Single-cell analysis of intestinal lymphocytes reveals targets for treatment of inflammatory bowel disease | 2020 |
| 323 | Controlling MAC | Structural basis of controlling the membrane attack complex | 2020 |
| 324 | REpAIR | Spatio-Temporal Regulation of Inflammation and Tissue Regeneration: Studying the immune system - tissue - microbiota communication to develop targeted therapies for immune-mediated diseases and cancer | 2020 |
| 325 | H I C I | Transcriptional and epigenetic control of tissue regenerative HB-EGF in autoimmune CNS inflammation | 2020 |
| 326 | MacinNASH | Revealing the contribution of liver macrophage populations to NASH in insulin resistance | 2020 |
| 327 | NICHEADAPT | Deciphering the niche adaptations of a gut commensal involved in educating the host immune system | 2021 |
| 328 | ExpoBiome | Deciphering the impact of exposures from the gut microbiome-derived molecular complex in human health and disease | 2020 |
| 329 | MicroSynCom | Mechanisms of Microglia Synapse Communication | 2020 |
| 330 | C.A.R.E. OA | Cross-linking Adenosine Receptors - Estrogen receptors for OA treatment | 2021 |
| 331 | EXPLOSIA | EXpansion and Phenotype Loss Of SMCs In Atherosclerosis: Causal effects and therapeutic possibilities | 2020 |
| 332 | MiNeMI | Micronnedle-assisted nanovector skin patch for immunomodulation of the inflammatory response upon occurrence of myocardial infarction injury (MiNeMi) | 2020 |
| 333 | INTEGRATE | Personalised Medicine for Intervertebral Disc Regeneration- Integrating Profiling, Predictive Modelling and Gene Activated Biomaterials | 2020 |
| 334 | immunoassays | Development of new immunoassays for the diagnosis and prediction of drug-related complement pathology | 2020 |
| 335 | TS4NC | TS4NC: Therapeutic S4N Chelation targeting Alzheimer's Disease. | 2020 |
| 336 | MacrophageEGR | Egr1 and Egr2 regulate opposite transcriptional programs in macrophages | 2021 |
| 337 | AlzheimersInAction | AlzheimersInAction: A multi-disciplinary approach to determine the cellular and molecular mechanisms underlying the inflammatory response to amyloid-β in Alzheimer’s disease. | 2021 |
| 338 | GUTMAPS | Cellular cartography of the intestine in health and inflammation | 2021 |
| 339 | PATHOCODE | Molecular pathology of anti-viral T cell responses in the central nervous system | 2020 |
| 340 | DIM-CrIC | Decreasing Pancreatic Adenocarcinoma-related Inflammation using small molecule inhibitors of STING | 2020 |
| 341 | VirIVITES | ARBOVIRUS SKIN INFECTION MODELLING FOR MORE ACCURATE VIRAL PATHOGENESIS | 2020 |
| 342 | MUCO-IMMUN | MUCOBIOME-MEDIATED IMMUNE PATHWAYS IN INFLAMMATORY BOWEL DISEASES | 2020 |
| 343 | APT | The Sound of a Healthy Herd. Revolutionising the Care of Dairy Cattle with Pioneering Acoustic Technology | 2020 |